Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Uvadex extracorporeal photopheresis plus corticosteroids for newly diagnosed acute graft-versus-host disease
2004-003774-29Phase 3Completed
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of methoxsalen and corticosteroids in Acute Graft-Versus-Host Disease (aGvHD) (2 arms), sponsored by Mallinckrodt Pharmaceuticals. Primary endpoint: Primary efficacy endpoint. Started Oct 2005; status: completed.
02
Drugs
methoxsalencorticosteroids
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on 2004-003774-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003774-29.